# Dame Ottoline Leyser

> Dame Ottoline Leyser is a grant investor at UK Research and Innovation backing Medical. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [UK Research and Innovation](https://shizune.co/investors/profile/uk-research-and-innovation)
- Total investments: 1
- Last investment: Feb 2023
- Lead investor: 100%
- Last updated: Aug 2026
- X (Twitter): https://twitter.com/ukri_ceo
- Website: https://x.com/ukri_ceo

Dame Ottoline Leyser is a grant investor at UK Research and Innovation focused on Medical and Education. Professor Dame Ottoline Leyser is the Chief Executive of UK Research and Innovation (UKRI).

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Education | 1 | 100% |
| Biotechnology | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Rosalind Franklin Institute | Rosalind Franklin Institute focuses on transforming life science through research and technology development. Their technologies will enable the imaging of life in five dimensions. The Institute works with industrial and academic partners fostering interdisciplinary research with real impact in imaging, diagnostics, drug development, and many morefields. | $48.3M | Grant | Feb 10, 2023 |  |

1 of 1 investments shown.

## About UK Research and Innovation

VC Fund · Swindon, United Kingdom

UKRI intends to be an outstanding organisation that ensures the UK maintains its world leading position in research and innovation.

5 contacts available at UK Research and Innovation.

| Name | Title | Profile |
| --- | --- | --- |
| Dame Ottoline Leyser | CEO | https://shizune.co/investors/profile/dame-ottoline-leyser |
| Damien Hatton | Service Design Lead | https://shizune.co/investors/profile/damien-hatton |
| Dario Canale | Head of UKRI Creative Services (JRS) | https://shizune.co/investors/profile/dario-canale |
| Disa Lee Choun | Assessor | https://shizune.co/investors/profile/disa-lee-choun |
| George MacGinnis | Healthy Ageing Challenge DirectorHealthy | https://shizune.co/investors/profile/george-macginnis-618f |

## Similar investors

### Similar stage
- [Scottish Enterprise](https://shizune.co/investors/profile/scottish-enterprise) — VC Fund
- [Foundation for Innovation and Technology (FIT)](https://shizune.co/investors/profile/foundation-pour-l-innovation-technologique) — VC Fund
- [Business Finland](https://shizune.co/investors/profile/tekes) — VC Fund

## FAQ

### What does Dame Ottoline Leyser invest in?

Dame Ottoline Leyser invests primarily in Medical, Education and Biotechnology startups, most often at Grant stage. Most of the 1 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Dame Ottoline Leyser last invest?

The most recent investment recorded for Dame Ottoline Leyser closed in Feb 2023. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co